Federal contract award
HT942524C0049
SBIR PHASE III PROPOSAL NO. JW230017 TITLED, "OPTIMIZED, FIELD-STABLE GLYCOPOLYMER-MIMICKING POLYSACCHARIDE TO PREVENT MORBIDITY AND MORTALITY IN EXPOSURE TO IONIZING RADIATION OR NUCLEAR INJURY"
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.3M |
| Current contract value | $2.3M |
| Potential contract value / ceiling | $2.3M |
| Start date | Sep 20, 2024 |
| Current end date | Sep 19, 2026 |
| Potential end date | Sep 19, 2026 |
| Latest award activity | Mar 24, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 24, 2025 | P00001 | $0 | SBIR PHASE III PROPOSAL NO. JW230017 TO FURTHER DEVELOP AN ORALLY DELIVERED DRUG PRODUCT TO TREAT INJURY TO, AND INFLAMMATION OF, THE GASTROINTESTINAL TRACT. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.